MARKET

ELAN

ELAN

Elanco Animal Health
NYSE
13.46
+0.53
+4.10%
Closed 16:06 04/23 EDT
OPEN
13.00
PREV CLOSE
12.93
HIGH
13.73
LOW
12.98
VOLUME
4.79M
TURNOVER
0
52 WEEK HIGH
16.88
52 WEEK LOW
7.88
MARKET CAP
6.65B
P/E (TTM)
-5.3829
1D
5D
1M
3M
1Y
5Y
Elanco's 'Parvo is Poop' Campaign Unleashes Awareness and Action on National Parvo Awareness Day
Launches first-ever tracking site for often-fatal parvovirus outbreaks to save 1 million puppies by 2030. Elanco declares April 23 as the first ever National Parvo Awareness Day. Parvo is estimated to affect more than 330,000 puppies a year. Only 44% of consumers are aware of parvo and its symptoms.
PR Newswire · 23h ago
Benign Growth For Elanco Animal Health Incorporated (NYSE:ELAN) Underpins Its Share Price
Elanco Animal Health Incorporated's price-to-sales ratio of 1.4x is lower than the Pharmaceuticals industry. The company has been growing revenue less than most other companies lately. The low P/S ratio may be due to the company's lacklustre revenue growth forecast. It's trading at a lower price to sales ratio than the broader industry.
Simply Wall St · 2d ago
Weekly Report: what happened at ELAN last week (0415-0419)?
Weekly Report · 2d ago
Elanco Confirms Date and Conference Call for First Quarter 2024 Financial Results Announcement
Elanco Animal Health Incorporated will announce its first quarter 2024 financial results on Wednesday, May 8, 2024. The company will conduct a conference call to further detail the company's performance. The conference call will be webcast live on Elanco's website. Elanco is a global leader in animal health.
PR Newswire · 04/17 12:00
Weekly Report: what happened at ELAN last week (0408-0412)?
Weekly Report · 04/15 09:09
FDA Approved Pradalex (Pradofloxacin Injection) Solution For Certain Respiratory Diseases In Cattle And Swine; Approves New Antimicrobial Drug For Cattle And Swine; Pradalex Is Sponsored By Elanco U.S.
Benzinga · 04/09 17:10
BRIEF-FDA Approved Pradalex Solution For Certain Respiratory Diseases In Cattle And Swine
FDA Approved Pradalex Solution For Certain Respiratory Diseases In Cattle And Swine. FDA approved the drug for treatment of certain respiratory diseases in cattle and swine. The drug is not intended for use in sheep or pigs, the company says.
Reuters · 04/09 17:06
FDA: PRADALEX IS SPONSORED BY ELANCO US INC.
Reuters · 04/09 17:01
More
About ELAN
Elanco Animal Health Incorporated is an animal health company. The Company is focused in delivering products and services to prevent and treat disease in farm animals and pets. Its portfolio serves animals across its core species consisting of dogs, cats and cattle, poultry, swine, sheep and aqua. It offers products in two primary categories: Pet Health and Farm Animal. Its Pet Health portfolio is focused on parasiticides, vaccines and therapeutics. Its Pet Health portfolio products that protect pets from fleas, ticks and internal parasites. Its Farm Animal portfolio of products is primarily focused on cattle, swine, poultry, and aquaculture. Its Pet Health products include Advantage Family, Atopica, Claro/ Neptra, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its Farm Animal products include AviPro, Baycox, Catosal, Comforta, Denagard, Experior, Hemicell, Maxiban, Monteban, Pulmotil, Rumensin, and others.

Webull offers Elanco Animal Health Inc stock information, including NYSE: ELAN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ELAN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ELAN stock methods without spending real money on the virtual paper trading platform.